03 Dec 2019

IAC CONDUCTS ACCREDITATION PERCEPTIONS SURVEY

Authentic Testing has been engaged by the Intersocietal Accreditation Commission (IAC) to understand perceptions related to the value of imaging and procedural accreditation across multiple medical specialties. The results of the survey will help guide future quality initiatives to meet the needs of the medical community and to improve the

0
12 Nov 2019

SOME ACADEMICS QUIETLY TAKE SIDE JOBS HELPING TOBACCO COMPANIES IN COURT

  By Blake Farmer Nashville Public Radio   In 1998, major reached a historic legal settlement with states that had sued them over the health care costs of smoking-related illnesses. But individual smokers have continued to sue, and to this day the tobacco industry remains tied up in hundreds of court

0
30 Oct 2019

IVUS invaluable for precise iliac vein treatment; SVS Study free to public through Dec. 31

 In a large series of iliac vein stent cases, a blinded comparison found intravascular ultrasound (IVUS) superior to venography in determining the proper location of treatment zones.   Researchers from The RANE Center at St. Dominic’s Memorial Hospital in Jackson, Miss., have performed a retrospective, single-center cohort study of 155

0
26 Aug 2019

COMING OUT ABOUT MENTAL HEALTH ON SOCIAL MEDIA

By Tarena Lofton Susanna Harris was sitting in her lab class for her graduate program at the University of North Carolina at Chapel Hill when she received an email that told her she had failed what she describes as “the most important exam in grad school,” the doctoral qualifying exam.

0
26 Jun 2019

VIVA AND THE VEINS 2019: Dr. Suresh Vedantham to receive VEIN Award; abstracts now being accepted

Suresh Vedantham, MD, past president of the Society of Interventional Radiology, will receive the 2019 Venous Educator, Innovator, and National Statesman Award (VEIN AWARD) during VIVA and The VEINS2019 conference Nov. 4-7 at the Wynn Las Vegas. Dr. Vedantham is a professor of Radiology & Surgery at the Mallinckrodt Institute of Radiology at the

0
26 Jun 2019

CHARING CROSS 2019: MEDTRONIC EXPANDS ON KEY AORTIC SOLUTIONS FOR CHALLENGING ANATOMIES

  Medtronic plc released new data on endovascular repair of abdominal aortic aneurysm (AAA) patients with the Endurant II/IIs stent graft system in combination with Heli-FX EndoAnchor implants and for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR). The data, which was presented at the Charing Cross

0
26 Jun 2019

ABBVIE ACQUIRING ALLERGAN AS HEDGE AGAINST EXPIRATION OF HUMIRA PATENT

As a hedge against the 2023 expiration of its U.S. patents that protect its blockbuster drug, Humira, AbbVie Inc. will acquire Dublin, Ireland-based Allergan for $63 billion in cash and stock.     Humira sales account for more than 60 percent of AbbVie’s revenue, but biosimilar drugs approved in Europe

0
13 Jun 2019

DO YOUR OLDER PATIENTS REGARD THEIR HEALTH AS GOOD OR POOR?

    By Judith Graham A common myth about aging is that older adults are burdened by illness and feel lousy much of the time. In fact, the opposite is usually true. Most seniors report feeling distinctly positive about their health. Consider data from the 2017 National Health Interview Survey (the most

0
12 Jun 2019

VICI VENOUS STENT: FDA OKs VICI Venous Stent to treat Iliofemoral obstructive disease

    The U.S Food and Drug Administration has approved Boston Scientific’s VICI Venous Stent System for the treatment of iliofemoral venous obstructive disease, which occurs when the flow of blood through the veins located deep in the pelvic region becomes blocked by a blood clot or compressed by anatomical anomalies.

0
12 Jun 2019

VECLOSE EXTENSION STUDY: Five-year outcomes prove durability, safety, efficacy of VenaSeal Closure System

    By Larry Storer Five-year results from the 2019 VeClose Extension Study of the Medtronic VenaSeal Closure System demonstrate that the treatment modality is consistent, durable and safe for permanently closing veins in patients with venous reflux disease. When compared with Medtronic Radiofrequency Ablation, VenaSeal continued to show “non-inferiority”

0